人呼吸道合胞病毒（hRSV）是世界范围内婴幼儿下呼吸道感染的重要病原病毒之一，至今缺乏有效的hRSV感染治疗药物和疫苗。从中药有效成分、单味中药、中药复方抑制剂研发3个方面，对抗hRSV感染中药的最新研究进展进行综述，为抗hRSV新药研发与探索新的hRSV感染的治疗策略奠定理论基础。

Human respiratory syncytial virus (hRSV) was considered to be the leading cause of lower respiratory tract disease in infants and young children. So far, there was a lack of effective anti-hRSV drugs and vaccines. In this paper, the latest research progress on anti hRSV infection drugs was reviewed from three aspects of effective constituents of Chinese materia medica, Chinese materia medica, and Chinese medicine compound antiviral inhibitor research and development, which would lay a theoretical foundation for the research and development of anti-hRSV drugs and the anti hRSV infection treatment strategy.

山东省高校中医药抗病毒协同创新中心资助项目（XTCX2014B-01）；山东省自然科学基金资助项目（ZR2013HM035）